Dr. van 't Veer on Guidelines for Genetic Testing in Breast Cancer

Laura van 't Veer, PhD
Published: Friday, Oct 27, 2017



Laura van ’t Veer, PhD, Leader of the Breast Oncology Program, and director of Applied Genomics, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the guidelines for genetic testing in breast cancer.

For women who are diagnosed with breast cancer and have a family history, the guidelines for genetic testing are quite clear. But information of genetic risk is relevant for every woman, regardless of family history, states van ‘t Veer.

Nowadays, physicians can look at the genetics of a given patient for a risk score to advise screening decisions.
 


Laura van ’t Veer, PhD, Leader of the Breast Oncology Program, and director of Applied Genomics, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the guidelines for genetic testing in breast cancer.

For women who are diagnosed with breast cancer and have a family history, the guidelines for genetic testing are quite clear. But information of genetic risk is relevant for every woman, regardless of family history, states van ‘t Veer.

Nowadays, physicians can look at the genetics of a given patient for a risk score to advise screening decisions.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x